Vertex Pharmaceuticals Inc. closed 10.29% short of its 52-week high of $519.88, which the company achieved on November 8th.

CoreWeave shares are in focus as the AI infrastructure firm confirms plans of buying Core Scientific for $9 billion.

Add these creatine-rich foods to your diet to help improve exercise performance, strength, muscle recovery and more. Updated March 10, 2025, 5:23 AM PDT / Source: TODAY Caroline Kee Health reporter ...

PGIM Jennison Health Sciences Fund’s Q1 2025 letter highlights mixed sector returns, with Vertex Pharmaceuticals in focus.